Citations

Clear

4 citation(s) found for "Ghorbani, Mohammad".

Intracranial hypertension and papilledema secondary to an unruptured arteriovenous malformation: Review of the literature
Griessenauer, Christoph J. , Bahrami, Reza , Mirsardoo, Hojjat, Sahraei, Rana, Mortazavi, Abolghasem , Griessenauer, Christoph J , Wipplinger, Christoph , Mortazavi, Abolghasem , Ghorbani, Mohammad

Mayo Clinic

The Neuroradiology Journal | November 21, 2024 | Volume: 38 | Issue: 4 | Pages: 387-393

10.1177/19714009241303068 | PMID 39572165 Get It

Arteriovenous malformations (AVMs) are abnormal connections of arteries and veins without intermediate capillary components. As such, AVMs can remain asymptomatic or have a variety of clinical presentations ranging from mild headaches to severe symptoms like seizures, hemorrhage, and subsequent coma. Papilledema and increased intracranial pressure without hydrocephalus or hemorrhage are rare forms of presentations of cerebral AVM. The mechanism of intracranial hypertension accompanying brain AVMs is not entirely understood, and the right treatment strategy is controversial. Here, we present the treatment and outcomes of four patients with unruptured AVMs who presented with intracranial hypertension accompanied by visual symptoms, papilledema, and without evidence of hydrocephalus. In cases of AVMs accompanied by intracranial hypertension, AVM treatment should be considered the main target of management.
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure
Feio‐Azevedo, Rita , Boesch, Markus , Radenkovic, Silvia , Melkebeke, Lukas Van , Smets, Lena , Wallays, Marie , Philips, Gino, Oliveira, Janaíne Prata de , Ghorbani, Mohammad , Laleman, Wim , Meersseman, Philippe , Wilmer, Alexander , Cassiman, David , Malenstein, Hannah van , Sánchez, Cristina, Aguilar, Ferrán , Nevens, Frederik , Verbeek, Jef , Denadai‐Souza, Alexandre , Lambrechts, Diether , Korf, Hannelie , Merwe, Van der , Lambrechts, Diether , Lambrechts, Diether , Lambrechts, Diether , Verbeek, Jef , Boeckx, Bram , Triantafyllou, Evangelos , Moreau, Richard , Arroyo, Vicente , Clària, Joan , Ghesquière, Bart

Mayo Clinic

Hepatology | May 18, 2024 | Volume: 81 | Issue: 2 | Pages: 509-522

10.1097/hep.0000000000000907 | PMID 38761406 Get It

Background and Aims: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading to organ failure, along with immune dysfunction that heightens susceptibility to bacterial infections. However, it is unclear how these aspects are associated with recovery and nonrecovery in ACLF. Approach and Results: Here, we mapped the single-cell transcriptome of circulating immune cells from patients with ACLF and acute decompensated (AD) cirrhosis and healthy individuals. We further interrogate how these findings, as well as immunometabolic and functional profiles, associate with ACLF-recovery (ACLF-R) or nonrecovery (ACLF-NR). Our analysis unveiled 2 distinct states of classical monocytes (cMons). Hereto, ACLF-R cMons were characterized by transcripts associated with immune and stress tolerance, including anti-inflammatory genes such as RETN and LGALS1. Additional metabolomic and functional validation experiments implicated an elevated oxidative phosphorylation metabolic program as well as an impaired ACLF-R cMon functionality. Interestingly, we observed a common stress-induced tolerant state, oxidative phosphorylation program, and blunted activation among lymphoid populations in patients with ACLF-R. Conversely, ACLF-NR cMon featured elevated expression of inflammatory and stress response genes such as VIM, LGALS2, and TREM1, along with blunted metabolic activity and increased functionality. Conclusions: This study identifies distinct immunometabolic cellular states that contribute to disease outcomes in patients with ACLF. Our findings provide valuable insights into the pathogenesis of ACLF, shedding light on factors driving either recovery or nonrecovery phenotypes, which may be harnessed as potential therapeutic targets in the future.
Comparison of PED and FRED flow diverters for posterior circulation aneurysms: a propensity score matched cohort study
Enríquez-Marulanda, Alejandro , Xiang, Sissi, Zhang, Hongqi , Waqas, Muhammad , Tutino, Vincent M. , Siddiqui, Adnan H. , Ogilvy, Christopher S. , Ulfert, Christian , Möhlenbruch, Markus , Renieri, Leonardo , Limbucci, Nicola , Burkhardt, Jan‐Karl , Kan, Peter , Rinaldo, Lorenzo , Brinjikji, Waleed , Spears, Julian , Broussalis, Erasmia , Koçer, Naci , Sonnberger, Michael , Engelhorn, Tobias , Ghuman, Mandeep S. , Salehani, Arsalaan , Harrigan, Mark R. , Radovanovic, Ivan , Chen, Karen , Aziz‐Sultan, Mohammad Ali , Ghorbani, Mohammad , Schirmer, Clemens M. , Goren, Oded , Dalal, Shamsher , Koch, Matthew J. , Stapleton, Christopher J. , Patel, Aman B. , Finkenzeller, Thomas , Holtmannspötter, Markus, Buhk, Jan Hendrik, Foreman, Paul M. , Cress, Marshall C. , Hirschl, Robert , Reith, W. , Janssen, Hendrik , Marotta, Thomas R. , Dmytriw, Adam A. , Waqas, Muhammad , Siddiqui, Adnan H , Levy, Elad I , Thomas, Ajith J , Renieri, Leonardo , Parra-Fariñas, Carmen , Rinaldo, Lorenzo , Brinjikji, Waleed , Müller-Thies-Broussalis, Erasmia , Killer-Oberpfalzer, Monika , Koch, Matthew J , Simgen, Andreas , Janssen, Hendrik , Marotta, Thomas R , Dmytriw, Adam A , Tutino, Vincent M , Schirmer, Clemens M , Ulfert, Christian , Limbucci, Nicola , Ogilvy, Christopher S , Griessenauer, Christoph J. , Hong, Tao , Taussky, Philipp , Grandhi, Ramesh , Levy, Elad I. , Lanzino, Giuseppe , Işlak, Civan , Yang, Victor X. D. , Mendes Pereira, Vitor , Krings, Timo , Matouk, Charles

Mayo Clinic

Journal of NeuroInterventional Surgery | July 1, 2020 | Volume: 13 | Issue: 2 | Pages: 153-158

10.1136/neurintsurg-2020-016055 | PMID 32611622 Get It

Abstract Background Flow diversion is a common endovascular treatment for cerebral aneurysms, but studies comparing different types of flow diverters are scarce. Objective To perform a propensity score matched cohort study comparing the Pipeline Embolization Device (PED) and Flow Redirection Intraluminal Device (FRED) for posterior circulation aneurysms. Methods Consecutive aneurysms of the posterior circulation treated at 25 neurovascular centers with either PED or FRED were collected. Propensity score matching was used to control for age, duration of follow-up imaging, adjunctive coiling, and aneurysm location, size, and morphology; previously ruptured aneurysms were excluded. The two devices were compared for the following outcomes: procedural complications, aneurysm occlusion, and functional outcome. Results A total of 375 aneurysms of the posterior circulation were treated in 369 patients. The PED was used in 285 (77.2%) and FRED in 84 (22.8%) procedures. Aneurysms treated with the PED were more commonly fusiform and larger than those treated with FRED. To account for these important differences, propensity score matching was performed resulting in 33 PED and FRED unruptured aneurysm pairs. No differences were found in occlusion status and neurologic thromboembolic or hemorrhagic complications between the two devices. The proportion of patients with favorable functional outcome was higher with FRED (100% vs 87.9%, p=0.04). Conclusion Comparative analysis of PED and FRED for the treatment of unruptured posterior circulation aneurysms did not identify significant differences in aneurysm occlusion or neurologic complications. Variations in functional outcomes warrant additional investigations.
Experience With the Pipeline Embolization Device for Posterior Circulations Aneurysms: A Multicenter Cohort Study
Enríquez-Marulanda, Alejandro , Biswas, Arundhati , Xiang, Sissi, Rinaldo, Lorenzo , Brinjikji, Waleed , Burkhardt, Jan‐Karl , Kan, Peter , Ghuman, Mandeep S. , Chen, Karen , Aziz‐Sultan, Mohammad Ali , Ghorbani, Mohammad , Schirmer, Clemens M. , Goren, Oded , Dalal, Shamsher , Broussalis, Erasmia , Koch, Matthew J. , Stapleton, Christopher J. , Patel, Aman B. , Foreman, Paul M. , Cress, Marshall C. , Hirschl, Robert , Zhang, Hongqi , Dmytriw, Adam A. , Rinaldo, Lorenzo , Dmytriw, Adam A , Schirmer, Clemens M , Griessenauer, Christoph J. , Taussky, Philipp , Grandhi, Ramesh , Hong, Tao , Lanzino, Giuseppe , Yang, Victor X. D. , Killer-Oberpfalzer, Monika , Krings, Timo

Mayo Clinic

Neurosurgery | June 5, 2020 | Volume: 87 | Issue: 6 | Pages: 1252-1261

10.1093/neuros/nyaa277 | PMID 32629474 Get It

Abstract BACKGROUND The Pipeline Embolization Device (PED; Medtronic) has been used off-label for the treatment of challenging posterior circulation aneurysms. Data on this modality are primarily limited to small retrospective single-center series. OBJECTIVE To assess safety and efficacy of this treatment by establishing an international, multicenter collaboration. METHODS Consecutive posterior circulation aneurysms treated with the PED from 2012 to 2019 across 11 neurovascular centers were retrospectively reviewed. Baseline demographics, aneurysm and treatment characteristics, complications, occlusion status, and functional outcome were assessed. RESULTS There were 149 posterior circulation aneurysms treated with PED in 146 patients. A total of 24 (16.4%) patients presented with subarachnoid hemorrhage. Most aneurysms were dissecting/blister (36.2%) in morphology, followed by saccular (35.6%) and fusiform (28.2%). The most common locations were the vertebral (51.7%) and basilar arteries (22.8%). Complete or near-complete occlusion (>90%) was achieved in 90.9% of aneurysms at a median follow-up of 12 mo. Dissecting/blister aneurysms were most likely to occlude ( P = .06). Symptomatic neurologic complications occurred in 9.4% of aneurysms, associated with larger size, ruptured presentation, presentations with brain stem compression, cranial nerve palsy, or stroke. Favorable functional outcome (modified Rankin Score 0-2) was achieved in 86.2% of patients. There were 6 fatalities of which 4 occurred in aneurysmal subarachnoid hemorrhage patients. CONCLUSION This multicenter study shows that PED for the treatment of posterior circulation is preferentially used for the treatment of fusiform and dissecting/blister aneurysm morphologies. Despite the challenges presented by these less-common morphologies, flow diversion may be performed with a neurologic complication rate of about 10% and favorable long-term aneurysm occlusion rates.